Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: MJNA

Medical Marijuana, Inc. Applauds Mexico President for Signing Bill to Officially Legalize Medical Marijuana in Mexico

Medical Marijuana Inc., First Company to Provide Mexican Citizens Access to Medical Marijuana, Congratulates Cannabis Advocates in Mexico on Medical Cannabis Legalization

SAN DIEGO, June 22, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it applauds Mexico President Pena Nieto for signing a bill into law June 19 that officially legalized the cultivation, production, and use of cannabis products with less than 1% THC for medical use in Mexico.

The new law, which was approved by Mexico lawmakers earlier this year by an overwhelming majority, will direct Mexico’s ministry of Health to draft and implement policies to regulate the use, importation, and production of pharmaceutical products derived from cannabidiol (CBD)-dominant/low-THC cannabis.

“This historic change in policy for this critical Latin America nation is a momentous achievement for the over 120 million Mexican citizens who can now benefit from …

Continue Reading

Posted in Client News| Tagged , , |

Medical Marijuana, Inc. Subsidiary Kannaway® Adds New Full-Spectrum Hemp Oil Product to Line of CBD Hemp Oil Lifestyle Products

Company Introduces New Premium Hemp Oil Liquid for First Time at Largest Red Carpet Event in Its History in New Orleans

SAN DIEGO, June 21, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has added a new full-spectrum hemp oil product “Kannaway Premium Hemp Oil Liquid” to its line of CBD hemp oil lifestyle products. Kannaway® introduced its Premium Hemp Oil Liquid for the first time on Sat., June 17, at its largest Red Carpet Event in Company history in New Orleans, La.

Kannaway Premium Hemp Oil Liquid is made with a full-spectrum cannabinoid blend. Each 4 oz. bottle contains 1000 mg of CBD from non-decarboxylated and decarboxylated hemp oil – over 33 mg of CBD per serving – combined with medium-chain triglyceride oil derived from wholesome coconut oil and sustainably sourced palm …

Continue Reading

Posted in Client News| Tagged , , , |

Medical Marijuana, Inc. Garners National News Coverage at 4th Annual Cannabis World Congress and Business Expo in New York

Getty Images, NBC News segment highlight articles and TV interviews about Company’s CBD hemp oil; feature executives speaking on burgeoning industry

SAN DIEGO, June 19, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it garnered extensive media coverage from the 4th Annual Cannabis World Congress and Business Expo in New York, which took place on June 14-16.

Medical Marijuana, Inc.’s CEO Dr. Stuart Titus spoke to several television and radio stations about the therapeutic properties of cannabis, recent breakthroughs in medical cannabis research, and the Company’s groundbreaking Real Scientific Hemp Oil™ (RSHO™) and zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™).

“We are grateful to the press and to the International Cannabis Association for serving as an effective platform to raise awareness on the plethora of benefits of cannabidiol (CBD),” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “The CWCBE …

Continue Reading

Posted in Client News| Tagged , , , |
Kannaway LLC (MJNA)

A Closer Look at Kannaway LLC

Kannaway LLC (MJNA)

We’re always in search of other leaders in the cannabis industry who support and provide products to those who utilize the healing powers of medicinal marijuana and other similar products. Kannaway LLC is a subsidiary of Medical Marijuana, Inc. (OTC: MJNA). Kannaway reigns as the first lifestyle network to provide hemp-based botanical products to consumers. Their innovated products supply consumers with access to herbal blends and oils that support health and wellness through natural means.

Who Kannaway Is

Kannaway continuously strives to provide individuals with holistically sound choices for supplements and skincare products. They’re the first direct marketing company of its kind to give consumers access to legal hemp products. In 2014, the Academy of Multi-level Marketing awarded them with the title of “Start-up of the Year,” which was attributed to their rapid growth and solid foundation. Today, they’re continuing to guide the path of the cannabis market in …

Continue Reading

Posted in Articles| Tagged , , , , |

Medical Marijuana, Inc. Major Investment AXIM Biotech Moves Forward With Development Of MedChew Rx Pharmaceutical Chewing Gum

SAN DIEGO, May 3, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc.’s (AXIM® Biotech) (OTC: AXIM) product development partner Quay Pharmaceuticals Ltd. (“Quay Pharma”) has obtained the relevant licenses from the British Home Office to import and work with the controlled drugs that are required to continue the development of AXIM MedChew Rx® pharmaceutical chewing gum products.

MedChew Rx® is being developed as a pharmaceutical drug to treat pain and spasticity associated with multiple sclerosis (MS). It is formulated with 5 mg of cannabidiol (CBD) and 5 mg of tetrahydrocannabinol (THC).

The value of the MS treatment market is estimated to reach $20 billion by 2024, according to research firm GlobalData. This growth is primarily driven by the continued development of new products and an increase in diagnosis rates across …

Continue Reading

Posted in Client News| Tagged , , , |
Medical Marijuana (MJNA)

MJNA Financial Numbers Tell Story of a Company on the Rise

Medical Marijuana (MJNA)

Medical Marijuana, Inc., traded publicly under the ticker symbol MJNA, has made history as the world’s first cannabis company to be publicly traded in the United States. 2016 was a big year for the company with record growth, international import permissions being granted by multiple government agencies, and promising clinical trial results from MJNA’s revolutionary product lines.

Financial Growth

In the last quarter of 2016, Medical Marijuana, Inc.’s revenue increased by 66 percent compared to the first quarter of 2016. The company also had a Net Comprehensive Income increase of 731 percent compared to the same figure in 2015. Finishing out 2016 with a net income of greater than $8 million, the company is poised to break even more financial records in 2017. At least part of MJNA’s landmark success can be attributed to its portfolio of subsidiaries and investments, including new IP filings, international licensing and promising findings …

Continue Reading

Posted in Articles| Tagged , , , , |